Literature DB >> 16893627

Dravet syndrome: a study of 53 patients.

Roberto Horacio Caraballo1, Natalio Fejerman.   

Abstract

OBJECTIVE: We analyzed the electroclinical features, treatment and evolution of patients with Dravet syndrome (DS).
MATERIAL AND METHODS: We evaluated the clinical records of 53 patients that met the diagnostic criteria of DS according to the ILAE classification of 1989 seen at our center between February 1990 and December 2004.
RESULTS: Thirty-four male and 19 female patients met the diagnostic criteria of DS. Mean time of follow-up was 10 years. The mean age at onset was 6 months and in all patients the seizures were associated with febrile illness. Myoclonias were found in 39 children. These seizures appeared between the ages of 1 and 5.5 years, with an average of 1 year and 5 months. The seizures were difficult to control with AEDs. All patients presented some degree of mental delay. At the age of 6 years, one of the children in our series presented kinesigenic paroxysmal dyskinesias. Twenty patients were placed on the ketogenic diet (KD). Two did not tolerate the KD and the diet was ineffective in five cases. The other 13 showed different degrees of control of seizures.
CONCLUSION: The present study confirms the severity and intractability of the seizures and the difficulties to make an early diagnosis in DS. The onset of febrile seizures or seizures related to infectious disease or vaccination, focal or generalized, prolonged in time and during the first year of life, is especially suggestive of DS. The final diagnosis is usually made after 2 or 3 years when the electroclinical picture is complete, but earlier diagnosis is desirable. Myoclonias are the most representative type of non-febrile seizures in this syndrome but are not always present. Cognitive development is poor in all patients. Treatment with the KD should be considered early. A ion-channel disorder could explain the association between DS and paroxysmal diskinesias, as seen in one of our patients.

Entities:  

Mesh:

Year:  2006        PMID: 16893627     DOI: 10.1016/j.eplepsyres.2005.11.026

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

Review 1.  "Electro-clinical syndromes" with onset in paediatric age: the highlights of the clinical-EEG, genetic and therapeutic advances.

Authors:  Pasquale Parisi; Alberto Verrotti; Maria Chiara Paolino; Rosa Castaldo; Filomena Ianniello; Alessandro Ferretti; Francesco Chiarelli; Maria Pia Villa
Journal:  Ital J Pediatr       Date:  2011-12-19       Impact factor: 2.638

Review 2.  SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.

Authors:  Alex C Bender; Richard P Morse; Rod C Scott; Gregory L Holmes; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Behav       Date:  2012-02-16       Impact factor: 2.937

Review 3.  Neuropsychological deficits in childhood epilepsy syndromes.

Authors:  William S MacAllister; Sarah G Schaffer
Journal:  Neuropsychol Rev       Date:  2007-10-26       Impact factor: 7.444

4.  Protective effect of the ketogenic diet in Scn1a mutant mice.

Authors:  Stacey B B Dutton; Nikki T Sawyer; Franck Kalume; Patricia Jumbo-Lucioni; Karin Borges; William A Catterall; Andrew Escayg
Journal:  Epilepsia       Date:  2011-07-29       Impact factor: 5.864

5.  "Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings.

Authors:  Pasquale Parisi; Alberto Spalice; Francesco Nicita; Laura Papetti; Fabiana Ursitti; Alberto Verrotti; Paola Iannetti; Maria Pia Villa
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

6.  Focal Scn1a knockdown induces cognitive impairment without seizures.

Authors:  Alex C Bender; Heather Natola; Christian Ndong; Gregory L Holmes; Rod C Scott; Pierre-Pascal Lenck-Santini
Journal:  Neurobiol Dis       Date:  2013-01-11       Impact factor: 5.996

7.  Epileptic encephalopathies in adults and childhood.

Authors:  Zekiye Kural; Ali Fahir Ozer
Journal:  Epilepsy Res Treat       Date:  2012-09-27

8.  COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences.

Authors:  Veronica Hood; Anne T Berg; Kelly G Knupp; Sookyong Koh; Linda Laux; Mary Anne Meskis; Quratulain Zulfiqar-Ali; M Scott Perry; Ingrid E Scheffer; Joseph Sullivan; Elaine Wirrell; Danielle M Andrade
Journal:  Epilepsia       Date:  2022-04-20       Impact factor: 6.740

9.  Dravet syndrome.

Authors:  Gemma Incorpora
Journal:  Ital J Pediatr       Date:  2009-09-08       Impact factor: 2.638

10.  Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study.

Authors:  Nienke E Verbeek; Nicoline A T van der Maas; Floor E Jansen; Marjan J A van Kempen; Dick Lindhout; Eva H Brilstra
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.